EcoDrugPlus

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSCMIG00000009643
Gene Symbol: ABCC1
4 Cross references
203 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 8

Ensembl ID : ENSCMIG00000012502
Gene Symbol: ABCC8
3 Cross references
246 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 9

Ensembl ID : ENSCMIG00000016431
Gene Symbol: ABCC9
3 Cross references
240 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSCMIG00000006084
Gene Symbol: ATP1B1
4 Cross references
291 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSCMIG00000007163
Gene Symbol: ATP1B3
4 Cross references
296 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSCMIG00000006960
Gene Symbol: ATR
4 Cross references
207 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCMIG00000019907
Gene Symbol: BRAF
3 Cross references
220 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSCMIG00000007255
Gene Symbol: BCL2
1 Cross references
228 Possible Orthologues:

Bcl2 Like 2

Ensembl ID : ENSCMIG00000015008
Gene Symbol: BCL2L2
4 Cross references
350 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSCMIG00000012521
Gene Symbol: BCR
4 Cross references
288 Possible Orthologues:

C-C Chemokine Receptor Type 9-Like

Ensembl ID : ENSCMIG00000014266
Gene Symbol: LOC103183383
4 Cross references
265 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSCMIG00000008881
Gene Symbol: CXCR4
3 Cross references
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).